Institute for Medical Microbiology and Hygiene
Franz-Josef-Strauß-Allee 11 - D-93053 Regensburg

Prof. Dr. Ralf Wagner

wagner ralf
phone +49 (0) 941 - 944 6452
fax +49 (0) 941 - 944 6484
e-mail This email address is being protected from spambots. You need JavaScript enabled to view it.
web www.wagner-lab.de

projects


.

our projects

All current projects of our research group at a glance:

Title and brief descriptions of the projects

EHVA

European HIV Vaccine AllianceFunding: European Union's Horizon 2020 Research and Innovation Programme Duration: January 2016 – December 2020 The European HIV Vaccine Alliance (EHVA) – funded by the European Union's H2020 Program – aims at discovering and evaluating new prophylactic and therapeutic HIV-1 vaccine candidates. The program is c...

Influence of HIV's glycan shield on the function and longevity of vaccine-induced immune responses

Funding: H.W. & J. Hector Stiftung Duration: January 2017 – December 2019     The development of an effective HIV vaccine represents the most promising approach to end the AIDS pandemic, and this will almost certainly require the generation of long-lived antibody responses. Humoral long-term immune responses are provided by plasma...

HFVac3

Clinical trial of a DIOS Trivalent Haemorrhagic Fever Vaccine Funding: Innovate UK Duration: September 2018 – August 2020 The HFVac3-project is based on the predecessor projects EVAC and Tri-LEMvac that also were funded by Innovate UK. Within ...

THERIN

A therapeutic vaccine to eradicate pre-malignant HPV16 and HPV18 infection and prevent cancer Funding: Eurostars Duration: July 2018 – June 2021 HPV infections causes more than 250 thousand deaths per year with more than 85 % of these occurring in middle- and low-income countries. The availably prophylactic vaccines are not suitable...


lab members, news and publications


.

our news

All news of our working group at a glance:

date
title
03. Apr. 2014 (15:27 Uhr)

our publications

All recent publications of our research group at a glance:

title
to the top of site